NOVEL STRATEGIES TOWARD THE DEVELOPMENT OF AN EFFECTIVE VACCINE TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ACQUIRED IMMUNODEFICIENCY VIRUS* (Q61641127)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	NOVEL STRATEGIES TOWARD THE DEVELOPMENT OF AN EFFECTIVE VACCINE TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ACQUIRED IMMUNODEFICIENCY VIRUS*	article

Statements

scholarly article

0 references

NOVEL STRATEGIES TOWARD THE DEVELOPMENT OF AN EFFECTIVE VACCINE TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ACQUIRED IMMUNODEFICIENCY VIRUS* (English)

0 references

1

object named as

Barbara Ensoli

0 references

author name string

Aurelio Cafaro

2

0 references

publication date

January 2001

0 references

Clinical Research and Regulatory Affairs

0 references

18

0 references

4

0 references

293-327

0 references

A vaccine for HIV type 1: the antibody perspective

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

HIV-1 neutralizing antibodies: how full is the bottle?

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

IgG surfaces as an important component in mucosal protection

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Vaccine developments

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Vaccination with Rev and Tat against AIDS.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Molecular cloning and expression of rhesus macaque and sooty mangabey interleukin 16: biologic activity and effect on simian immunodeficiency virus infection and/or replication

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Recombinant human CD40 ligand inhibits simian immunodeficiency virus replication: a role for interleukin- 16.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

T lymphocyte responses in HIV-1 infection: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Efficacy studies on a canarypox-rabies recombinant virus

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Sindbis virus vectors for expression in animal cells

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Alphavirus-based expression vectors: strategies and applications

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Suppressive effect of antibody on processing of T cell epitopes

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

The trans-activator gene of HTLV-III is essential for virus replication

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Tat protein induces self-perpetuating permissivity for productive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Tat toxoid as a component of a preventive vaccine in seronegative subjects

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Alloimmunization to prevent AIDS?

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Immunotherapy for recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

AIDS vaccine developments

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

AIDS vaccine developments

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

AIDS vaccine developments

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

CD8-suppressor factor and beta-chemokine function as a complementary mechanism to cognate immunity

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

A rational basis for mucosal vaccination against HIV infection

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Progress towards a vaccine to prevent sexual transmission of HIV.

1 reference

https://api.crossref.org/works/10.1081%2FCRP-100108179

21 January 2018

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1126/SCIENCE.283.5400.357

Identifiers

10.1081/CRP-100108179

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61641127&oldid=2045231513"